BARINTHUS BIOTHERAPEUT
1.3500
08-November-24 15:58:45
15 minutes delayed
Stocks
-0.1215
-8.26%
Today's range
1.3500 - 1.5100
ISIN
N/A
Source
NASDAQ
-
12 Jun 2023 07:30:00 By Nasdaq GlobeNewswire
-
Vaccitech Reports First Quarter 2023 Financial Results and Recent Corporate Developments
12 May 2023 08:00:57 By Nasdaq GlobeNewswire
-
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
28 Mar 2023 08:00:11 By Nasdaq GlobeNewswire
-
Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments
24 Mar 2023 08:06:29 By Nasdaq GlobeNewswire
-
Vaccitech Appoints Industry Veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer
30 Jan 2023 08:00:01 By Nasdaq GlobeNewswire
-
21 Nov 2022 10:31:34 By Nasdaq GlobeNewswire
-
Vaccitech Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
10 Nov 2022 16:30:00 By Nasdaq GlobeNewswire
-
Vaccitech to Present at Upcoming November Investors Conferences
09 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
07 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
02 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
31 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
27 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
Vaccitech to Present at Upcoming October Investor & Scientific Conferences
03 Oct 2022 16:30:00 By Nasdaq GlobeNewswire
-
Vaccitech Promotes Gemma Brown as Chief Financial Officer
20 Sep 2022 16:30:00 By Nasdaq GlobeNewswire
-
Vaccitech to Present at Upcoming September Investors Conferences
07 Sep 2022 16:01:00 By Nasdaq GlobeNewswire
-
Vaccitech Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
09 Aug 2022 16:15:00 By Nasdaq GlobeNewswire
-
Vaccitech to Present at the William Blair Biotech Focus Conference 2022
07 Jul 2022 16:15:00 By Nasdaq GlobeNewswire